首页> 美国卫生研究院文献>Journal of Cardiology Cases >Repetitive stent thrombosis in a patient who had resistance to both clopidogrel and prasugrel
【2h】

Repetitive stent thrombosis in a patient who had resistance to both clopidogrel and prasugrel

机译:对氯吡格雷和普拉格雷均耐药的患者的重复性支架血栓形成

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

Clopidogrel resistance is associated with stent thrombosis. Prasugrel achieves greater platelet inhibition with less variability among patients than does clopidogrel. Thus, a patient who had stent thrombosis due to clopidogrel resistance may receive prasugrel to prevent repeated episodes of stent thrombosis. This case report describes a case of repetitive stent thrombosis in which resistance not only to clopidogrel, but also to prasugrel, was observed.<>Learning objective: In the face of clopidogrel resistance, prescribing prasugrel may be an acceptable treatment option. However, cross-unresponsiveness may be observed between clopidogrel and prasugrel. Thus, platelet function assay should be performed in patients with stent thrombosis, even when clopidogrel is replaced with prasugrel.>
机译:氯吡格雷抵抗与支架内血栓形成有关。与氯吡格雷相比,普拉格雷对患者的血小板抑制作用更大,变异性更小。因此,因氯吡格雷抵抗而发生支架血栓形成的患者可接受普拉格雷,以防止支架血栓反复发作。该病例报告描述了一例重复性支架血栓形成,其中观察到不仅对氯吡格雷而且对普拉格雷耐药。 strong>学习目标:面对氯吡格雷耐药,处方普拉格雷可能是可以接受的治疗选择。但是,在氯吡格雷和普拉格雷之间可能会发现交叉反应迟钝。因此,即使将氯吡格雷替换为普拉格雷,对于有支架血栓形成的患者也应进行血小板功能测定。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号